Ace inhibitors in ssc patients display a risk factor for scleroderma renal crisis-a eustar analysis - Université de Lille Accéder directement au contenu
Article Dans Une Revue Arthritis Research & Therapy Année : 2020

Ace inhibitors in ssc patients display a risk factor for scleroderma renal crisis-a eustar analysis

Résumé

To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected cohort from the European Scleroderma Trial and Research Group (EUSTAR). SSc patients without prior SRC and at least one follow-up visit were included and analyzed regarding SRC, arterial hypertension, and medication focusing on antihypertensive medication and glucocorticoids (GC). Out of 14,524 patients in the database, we identified 7648 patients with at least one follow-up. In 27,450 person-years (py), 102 patients developed SRC representing an incidence of 3.72 (3.06-4.51) per 1000 py. In a multivariable time-to-event analysis adjusted for age, sex, disease severity, and onset, 88 of 6521 patients developed SRC. The use of ACEi displayed an increased risk for the development of SRC with a hazard ratio (HR) of 2.55 (95% confidence interval (CI) 1.65-3.95). Adjusting for arterial hypertension resulted in a HR of 2.04 (95%CI 1.29-3.24). There was no evidence for an interaction of ACEi and arterial hypertension (HR 0.83, 95%CI 0.32-2.13, p = 0.69). Calcium channel blockers (CCB), angiotensin receptor blockers (ARB), endothelin receptor antagonists, and GC-mostly in daily dosages below 15 mg of prednisolone-did not influence the hazard for SRC. ACEi in SSc patients with concomitant arterial hypertension display an independent risk factor for the development of SRC but are still first choice in SRC treatment. ARBs might be a safe alternative, yet the overall safety of alternative antihypertensive drugs in SSc patients needs to be further studied.
Fichier principal
Vignette du fichier
s13075-020-2141-2.pdf (1.18 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04419899 , version 1 (26-01-2024)

Licence

Identifiants

Citer

Lukas Butikofer, Pierre A. Varisco, O. Distler, Otylia Kowal-Bielecka, Yannick Allanore, et al.. Ace inhibitors in ssc patients display a risk factor for scleroderma renal crisis-a eustar analysis. Arthritis Research & Therapy, 2020, Arthritis Research & Therapy, 22, pp.59. ⟨10.1186/s13075-020-2141-2⟩. ⟨hal-04419899⟩

Collections

UNIV-LILLE
1 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More